Equities analysts expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to post $0.79 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.73 to $0.81. DENTSPLY SIRONA posted earnings per share of $0.87 during the same quarter last year, which suggests a negative year-over-year growth rate of 9.2%. The company is expected to announce its next quarterly earnings report on Monday, March 7th.
On average, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.89 per share for the current financial year, with EPS estimates ranging from $2.84 to $2.92. For the next year, analysts forecast that the company will report earnings of $3.18 per share, with EPS estimates ranging from $2.96 to $3.36. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. The business’s revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.67 earnings per share.
In related news, insider Walter Petersohn sold 86,431 shares of DENTSPLY SIRONA stock in a transaction that occurred on Wednesday, November 17th. The stock was sold at an average price of $54.18, for a total transaction of $4,682,831.58. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Lisa Yankie sold 1,903 shares of DENTSPLY SIRONA stock in a transaction on Friday, November 19th. The stock was sold at an average price of $52.63, for a total value of $100,154.89. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.
A number of institutional investors have recently modified their holdings of the stock. Liberty Wealth Management LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at $33,000. Exchange Traded Concepts LLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at about $36,000. First Command Bank bought a new position in DENTSPLY SIRONA during the 2nd quarter valued at approximately $38,000. Dark Forest Capital Management LP bought a new position in DENTSPLY SIRONA during the 3rd quarter valued at approximately $50,000. Finally, Evermay Wealth Management LLC bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $51,000. Institutional investors and hedge funds own 93.46% of the company’s stock.
NASDAQ:XRAY traded down $0.75 on Thursday, hitting $51.26. 1,163,448 shares of the stock were exchanged, compared to its average volume of 1,437,835. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA has a 52 week low of $50.54 and a 52 week high of $69.54. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.13 and a current ratio of 1.60. The company’s 50-day moving average price is $57.08 and its 200 day moving average price is $61.36.
DENTSPLY SIRONA Company Profile
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Further Reading: Straddles
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.